Protara Therapeutics, Inc.

NasdaqGM:TARA Stock Report

Market Cap: US$53.6m

Protara Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TARA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Sep 24SellUS$271,715Opaleye Management Inc.Company158,901US$1.71
10 Sep 24SellUS$114,251Opaleye Management Inc.Company61,992US$1.89
16 Jul 24SellUS$27,828Opaleye Management Inc.Company11,396US$2.44
11 Jul 24SellUS$175,842Opaleye Management Inc.Company74,551US$2.40
01 Jul 24SellUS$17,598Opaleye Management Inc.Company8,288US$2.12
28 Jun 24SellUS$142,503Opaleye Management Inc.Company64,568US$2.26
25 Jun 24SellUS$28,734Opaleye Management Inc.Company12,725US$2.26
31 May 24SellUS$44,008Opaleye Management Inc.Company15,054US$2.94
22 May 24SellUS$130,434Opaleye Management Inc.Company42,800US$3.06
17 May 24SellUS$230,326Opaleye Management Inc.Company70,885US$3.33
10 May 24SellUS$566,951Opaleye Management Inc.Company182,300US$3.11

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TARA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,570,1787.61%
Hedge Funds1,681,1548.15%
VC/PE Firms1,900,0009.21%
Institutions7,197,38334.9%
General Public8,281,05740.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 81.5%.

Top Shareholders

Top 25 shareholders own 58.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.21%
RA Capital Management, L.P.
1,900,000US$4.9m0%0.05%
8.15%
Opaleye Management Inc.
1,681,154US$4.4m-27%0.61%
4.57%
StemPoint Capital LP
942,857US$2.5m-4.19%0.7%
4.13%
Woodline Partners LP
851,567US$2.2m752%0.02%
4.01%
Jesse Shefferman
828,201US$2.2m-1.02%no data
3.93%
Tavistock Life Sciences
811,627US$2.1m0%0.12%
3.68%
The Vanguard Group, Inc.
759,612US$2.0m77.6%no data
3.3%
Citadel Advisors LLC
680,511US$1.8m2.28%no data
2.84%
Randall Marshall
585,600US$1.5m0%no data
2.78%
Velan Capital Partners LP
574,000US$1.5m19.6%1.44%
2.6%
Baker Bros. Advisors LP
536,832US$1.4m0%0.01%
1.63%
Renaissance Technologies LLC
336,740US$875.5k124%no data
1.47%
Heights Capital Management, Inc.
302,746US$787.1k0%0.29%
0.9%
Two Sigma Investments, LP
185,223US$481.6k18.9%no data
0.87%
Oppenheimer Asset Management Inc.
179,125US$465.7k40.8%no data
0.82%
Geode Capital Management, LLC
170,040US$442.1k21%no data
0.75%
Ikarian Capital, LLC
155,712US$404.8k-13.8%0.11%
0.73%
Two Sigma Advisers, LP
151,618US$394.2k88.3%no data
0.57%
BlackRock, Inc.
116,977US$304.1k1.48%no data
0.37%
Marshall Wace LLP
77,351US$201.1k0%no data
0.31%
Jacqueline Zummo
63,331US$164.7k0%no data
0.24%
Bridgeway Capital Management, LLC
49,200US$127.9k103%no data
0.22%
LPL Financial Corporation, Asset Management Arm
46,000US$119.6k4.55%no data
0.19%
BB&T Trust
40,000US$104.0k100%no data
0.16%
XTX Holdings Limited, Asset Management Arm
32,682US$85.0k0%0.01%